From October 2023 (Reiwa 5), 'Advertising' Disclosure Becomes Mandatory. Explanation of the Operational Standards for Stealth Marketing Regulations | MONOLITH LAW OFFICE | Tokyo, Japan

Tag: Advertisement Review

From October 2023 (Reiwa 5), 'Advertising' Disclosure Becomes Mandatory. Explanation of the Operational Standards for Stealth Marketing Regulations — 2023.09.22
From October 2023 (Reiwa 5), 'Advertising' Disclosure Becomes Mandatory. Explanation of the Oper.
Stealth marketing, or "stema" in Japanese, refers to advertisements that are disguised as non-advertisements. This includes instances where celebri...
General Corporate

How are 'Pharmaceuticals','Quasi-Drugs' and 'Cosmetics' Distinguished in Japan? — 2023.09.01
How are 'Pharmaceuticals','Quasi-Drugs' and 'Cosmetics' Distinguished in Japan?
The Pharmaceutical and Medical Device Act, officially known as the "Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceutic...
General Corporate

What are the Legal Regulations for Advertising Supplements? — 2023.08.25
What are the Legal Regulations for Advertising Supplements?
Supplements, while not medicines, are considered health foods. However, from the consumer's perspective, they are not simply ordinary foods consume...
General Corporate

Regulation of Cosmetic Advertising Expressions on LPs and Other E-commerce Sites — 2023.08.25
Regulation of Cosmetic Advertising Expressions on LPs and Other E-commerce Sites
When advertising cosmetics, in order to encourage more customers to purchase a variety of products, it is necessary to widely disseminate the posit...
General Corporate

What are the Advertising Regulations for CBD Products? A Lawyer Explains the Relationship with the Japanese Pharmaceutical Affairs Law and Other Related Laws — 2023.08.25
What are the Advertising Regulations for CBD Products? A Lawyer Explains the Relationship with t.
CBD (Cannabidiol) is one of the components found in what is commonly known as cannabis. Needless to say, in Japan, cannabis itself is illegal under...
General Corporate

Guidelines for Advertisements of Quasi-Drugs: Key Points to Consider — 2023.08.23
Guidelines for Advertisements of Quasi-Drugs: Key Points to Consider
When it comes to advertising products categorized as quasi-drugs, such as "medicinal cosmetics," there are specific guidelines that must be followe...
General Corporate

Points to Note Regarding Advertising Expressions for Cosmetics and Health Foods — 2023.08.17
Points to Note Regarding Advertising Expressions for Cosmetics and Health Foods
In the operation of women's media, there may be instances where specific cosmetics or health foods are introduced within articles.While it is neces...
General Corporate

An Attorney's Explanation on the Key Points of the Japanese Medical Advertising Guidelines — 2023.08.17
An Attorney's Explanation on the Key Points of the Japanese Medical Advertising Guidelines
When posting content such as advertisements, information provision, reviews, and personal experiences related to hospitals, clinics, and medical of...
General Corporate

Legal Regulations on Advertising Medicines: Explaining the Japanese Pharmaceutical Affairs Law — 2023.08.17
Legal Regulations on Advertising Medicines: Explaining the Japanese Pharmaceutical Affairs Law
On June 12, 2014, a part of the Japanese Pharmaceutical Affairs Law (currently known as the Act on Securing Quality, Efficacy and Safety of Product...
General Corporate

Definition of Supplements under the 'Japanese Act of Pharmaceutical and Medical Device' and Advertising Expressions to Take Caution — 2023.08.17
Definition of Supplements under the 'Japanese Act of Pharmaceutical and Medical Device' and Adve.
Many people use supplements to compensate for the nutrients they often lack in their daily lives. Supplements are not only found in drugstores, but...
General Corporate